CooperVision has acquired SynergEyes to enhance its specialty contact lens offerings in North America and drive innovation in the treatment of irregular corneas and keratoconus.

Information on the Target

CooperVision, a leader in the global contact lens market, has acquired SynergEyes to strengthen its Specialty EyeCare division and broaden its offerings in specialty contact lenses. Based in Carlsbad, California, SynergEyes is known for its innovative hybrid lens technologies and a diverse range of brands aimed at treating conditions such as irregular corneas, presbyopia, and astigmatism. This acquisition enhances CooperVision's extensive product lineup, particularly for the treatment of keratoconus and irregular cornea.

The move comes at a time when the demand for specialty contact lenses is on the rise, driven by practitioners' desire for differentiation and better treatment options for patients. By integrating SynergEyes' portfolio with CooperVision's existing products, the combined entity is positioned to deliver a comprehensive continuum of care for various ocular conditions.

Industry Overview in the Target’s Specific Country

The U.S. contact lens market is experiencing robust growth, propelled by advancements in lens technology and an increasing understanding of the benefits of specialty lenses. Consumers are becoming more aware of ocular health issues, le